Seeing Is Believing

Currently out of the existing stock ratings of Yaron Werber, 104 are a BUY (72.22%), 39 are a HOLD (27.08%), 1 are a SELL (0.69%).
Analyst Yaron Werber, currently employed at TD COWEN, carries an average stock price target met ratio of 62.22% that have a potential upside of 23.8% achieved within 387 days. Previously, Yaron Werber worked at COWEN.
Yaron Werber’s has documented 279 price targets and ratings displayed on 33 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on LEGN, Legend Biotech Corp at 22-Jan-2026.
Analyst best performing recommendations are on GMAB (GENMAB AS).
The best stock recommendation documented was for ARGX (ARGENX NV ADR) at 7/17/2023. The price target of $533 was fulfilled within 3 days with a profit of $48.57 (10.03%) receiving and performance score of 33.42.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 01-May-2020
$185
$-203.16 (-52.34%)
11 days ago
(20-Feb-2026)
5/6 (83.33%)
$-194.73 (-51.28%)
755
Hold Since 07-Aug-2024
$375
$-13.16 (-3.39%)
$325
12 days ago
(19-Feb-2026)
10/12 (83.33%)
$-4.73 (-1.25%)
350
Buy Since 02-Jan-2025
$432
$43.84 (11.29%)
$381
12 days ago
(19-Feb-2026)
7/8 (87.5%)
$52.27 (13.77%)
120
Buy Since 06-Feb-2026
$400
$11.84 (3.05%)
$270
25 days ago
(06-Feb-2026)
1/2 (50%)
$18.32 (4.80%)
330
Hold Since 20-May-2025
$347
$-41.16 (-10.60%)
$288
25 days ago
(06-Feb-2026)
1/2 (50%)
$-34.68 (-9.09%)
23
Which stock is Yaron Werber is most bullish on?
Which stock is Yaron Werber is most reserved on?
What Year was the first public recommendation made by Yaron Werber?